EGFR and glioblastoma: While the silencing of EGFR or RICTOR alone had no significant effect on xenograft tumor growth in vivo, silencing of EGFR and RICTOR simultaneously resulted in a complete eradication of tumors suggesting that the combined silencing of EGFR and RICTOR should be an effective means of treating GBM [44].